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Abstract
Background: Creatine kinase (CK) links phosphocreatine, an energy storage system, to cellular
ATPases. CK activity serves as a temporal and spatial buffer for ATP content, particularly in fast-
twitch skeletal muscles. The extraocular muscles are notoriously fast and active, suggesting the
need for efficient ATP buffering. This study tested the hypotheses that (1) CK isoform expression
and activity in rat extraocular muscles would be higher, and (2) the resistance of these muscles to
fatigue would depend on CK activity.
Results: We found that mRNA and protein levels for cytosolic and mitochondrial CK isoforms
were lower in the extraocular muscles than in extensor digitorum longus (EDL). Total CK activity
was correspondingly decreased in the extraocular muscles. Moreover, cytoskeletal components of
the sarcomeric M line, where a fraction of CK activity is found, were downregulated in the
extraocular muscles as was shown by immunocytochemistry and western blotting. CK inhibition
significantly accelerated the development of fatigue in EDL muscle bundles, but had no major effect
on the extraocular muscles. Searching for alternative ATP buffers that could compensate for the
relative lack of CK in extraocular muscles, we determined that mRNAs for two adenylate kinase
(AK) isoforms were expressed at higher levels in these muscles. Total AK activity was similar in
EDL and extraocular muscles.
Conclusion: These data indicate that the characteristic fatigue resistance of the extraocular
muscles does not depend on CK activity.
Background
In order to maintain a high effective free energy change of
ATP hydrolysis (∆GATP), metabolically active tissues need
to control cellular ATP and ADP levels within a relatively
narrow range. This is particularly true in skeletal muscle,
as its energy requirements can fluctuate rapidly by more
than two orders of magnitude. In mammalian skeletal
muscles and other tissues with widely fluctuating meta-
bolic needs, the creatine-phosphocreatine system buffers
intracellular ATP concentration: creatine kinase catalyzes
the reversible transfer of the phosphoryl group from phos-
phocreatine to ADP and sustains normal ATP levels [1].
Cellular creatine kinase (CK) activity is due to a family of
oligomeric enzymes: two cytosolic, ubiquitous "brain-
type" CK-B and "muscle-type" CK-M, and two mitochon-
drial isoforms, ubiquitous mitochondrial CK (uCK) and
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"sarcomeric" mitochondrial CK (sCK). The mitochondrial
CK isoforms are found as homo-octamers in the inner
mitochondrial membrane [2,3]. The cytosolic -M and -B
subunits form homo- and heterodimers, CK-MM, -MB-
and -BB isoenzymes [2]. In differentiated skeletal muscle,
CK-MM and sCK are the predominant isoforms. In fast-
twitch muscles, most CK activity is due to the CK-MM iso-
form, which is preferentially associated with the sarcom-
eric M line, the sarcoplasmic reticulum and T-tubules
[1,4]. This arrangement couples the CK-dependent ATP
buffering system to the cellular sites with the highest
ATPase activity, and is important for normal contractile
function [5,6]. In addition, targeting of CK to these cellu-
lar microenvironments localizes CK activity where it is
needed, optimizing enzyme distribution [7].
The extraocular muscles, responsible for voluntary and
reflexive movements of the eyes, are arguably the fastest
and most active skeletal muscles [8-10]. These muscles are
typically activated in a biphasic fashion: a high-intensity
burst followed by a lower-frequency step (pulse-step)
[11]. These functional properties depend on a reliable
energy supply and suggest that the extraocular muscles
may rely on cytosolic CK-M activity to a great extent. Fur-
thermore, the extraocular muscles are characterized by
abundant mitochondria and the presence of developmen-
tal and cardiac markers. Then, this muscle group may
potentially express CK-B and mitochondrial CK isoforms
at higher levels than limb skeletal muscles. Therefore, we
tested the hypotheses that (1) the expression and content
of CK isoforms and CK activity in rat extraocular muscles
would be higher than in fast limb skeletal muscle, and (2)
that the fatigue resistance of the extraocular muscles
would be critically dependent on normal CK activity. The
results showed that the expression and content of muscle-
specific cytosolic and mitochondrial CK isoforms is actu-
ally lower in extraocular muscle than in extensor digito-
rum longus (EDL), a prototypical fast limb skeletal
muscle. Hence, total CK activity in extraocular muscle is
significantly less than in EDL. In addition, the fatigue
resistance of the extraocular muscles is not altered when
CK activity is inhibited. These data are further evidence
that the extraocular muscles manage the metabolic load
imposed by their constant activity in a manner not usually
seen in typical fast skeletal muscles.
Results
Lower CK activity and isoform expression in extraocular 
muscle
We used quantitative PCR to compare the expression of all
the CK isoforms in the extraocular muscles and EDL. Mes-
sage for the main cytosolic CK isoform in skeletal muscle,
CK-M, was decreased in the extraocular muscles, as was
the other cytosolic isoform, CK-B (figure 1A). The lower
expression of cytosolic CK isoforms in extraocular muscle
does not result in a compensatory increase in the expres-
sion of the mitochondrial CKs: mRNA abundance for
muscle-specific sCK was also significantly less in the
extraocular muscles (figure 1A); uCK was found in EDL by
quantitative PCR, but it was below detectable levels in the
extraocular muscles. It can then be inferred that uCK
expression in these muscles is also significantly lower than
in EDL, although no relative comparison could be calcu-
lated. In turn, total CK activity in rat extraocular muscles
was only ~20% of that in the fast-twitch muscle EDL (4.1
± 0.6 vs. 20.7 ± 3.0 U/mg protein, respectively, figure 1B).
Figure 1C shows western blots that demonstrate that CK-
B and uCK isoforms were not detectable in EDL and
extraocular muscles. The muscle-specific isoforms CK-M
and sCK were found in the two muscles but not in brain.
CK-M protein content was less in the extraocular muscles.
Although the mitochondrial volume density of the
extraocular muscles is ~3- to 4-fold higher than in EDL
(McMullen and Andrade, not shown), sCK protein was
also less abundant in the extraocular muscles.
Less CK binding sites in extraocular muscle
A fraction of CK-M in skeletal muscles associates with the
sarcomeric M lines. Rat extraocular muscle fibers do not
have M lines [12,13]. Myomesin and M-protein, the main
cytoskeletal components of the M lines, were not detected
in extraocular muscles by immunocytochemistry, but
were clearly found in EDL fibers in a stereotypical banding
pattern (figure 2A). Western blotting failed to detect M-
protein in the extraocular muscles (figure 2B). On the
other hand, the extraocular muscles contained an alterna-
tively spliced isoform of myomesin, EH-myomesin. This
isoform was also detected in embryonic heart together
with myomesin (figure 2B). The level of M-protein mRNA
measured with quantitative PCR was correspondingly
lower in extraocular muscle (13.9-fold less than in EDL);
however, myomesin mRNA content was higher (2.1-fold
higher than in EDL).
Effect of CK inhibition on fatigue development
The baseline in vitro contractile properties of extraocular
and EDL muscles are presented in Table 1. Twitch kinetics
(time to peak twitch force, half-relaxation time, and
twitch-to-tetanus ratio) were significantly lower in the
extraocular muscles than in the EDL muscle bundles.
Maximal tetanic forces (P0) of the extraocular muscles
were only ~25% of the P0 generated by EDL bundles.
Although the contractile properties of the extraocular
muscles are very different from those of EDL, they are sim-
ilar to those reported previously by us and others [14,15].
In our initial experiments, extraocular muscles and EDL
bundles were incubated with the CK inhibitor 2,4-dinitro-
1-fluorobenzene (DNFB) immediately following the
determination of baseline contractile properties. To check
BMC Physiology 2005, 5:12 http://www.biomedcentral.com/1472-6793/5/12
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for non-specific DNFB-induced toxicity, its effect on P0
was measured with maximal tetanic contractions at 2-min
intervals for up to 30 min. DNFB at 50 µM resulted in a
drastic loss of force in EDL bundles after only 6 min; P0
decreased by 22.4 ± 3.5% from pre-DNFB baseline (n = 4
muscles, P < 0.05). The magnitude of the force drop in
extraocular muscles after 6 min in 50 µM DNFB was less
but still significant: P0 decreased by 12.1 ± 2.1% (n = 4
muscles, P < 0.05). On the other hand, DNFB at 10 µM for
= 20 min did not alter force significantly in either muscle
group: EDL 98.6 ± 1.1% of baseline, and extraocular mus-
cles 97.7 ± 2.0%, n = 4 muscles/each, P = not significant.
Therefore, for the rest of the study we incubated muscles
in 10 µM DNFB for 20 min, and then washed it out for 10
min before the start of the fatigue protocol. Five minutes
before the start of fatigue, during the washout period, P0
Lower CK isoform expression and activity in rat extraocular muscleFigur  1
Lower CK isoform expression and activity in rat 
extraocular muscle. (A) Relative abundance of three CK 
isoform mRNAs in EDL and extraocular muscle by quantita-
tive PCR. Each sample includes pooled muscles from 4 rats. 
Data are means from 3–4 samples, and are normalized to lev-
els measured in EDL = 100%. Message levels for the cytosolic 
CK-M and CK-B, and the mitochondrial sCK were much 
lower in extraocular muscles compared to EDL. (B) Total 
CK activity in EDL and extraocular muscles. EDL muscles 
have ~5-fold greater CK activity than extraocular muscles (n 
= 8, P < 0.001). (C) CK protein isoforms found in brain, EDL 
and extraocular muscle by western blot.
Myomesin and M-protein are downregulated in rat extraocu-lar musclesFigur  2
Myomesin and M-protein are downregulated in rat 
extraocular muscles. (A) Representative confocal micro-
graphs showing that myomesin and M-protein are found in 
EDL muscle fibers (EDL, top) in the same stereotypical band-
ing pattern, but are not detectable in extraocular muscle 
(EOM, bottom). Scale bar = 20 µm. (B) Western blots dem-
onstrating the presence of myomesin and M-protein in EDL 
and heart (H). Embryonic heart (He) did not have M-protein, 
but two bands reacted with the myomesin antibody: myo-
mesin and EH-myomesin, an alternatively spliced isoform of 
higher molecular weight. Extraocular muscle (EOM) con-
tained EH-myomesin, but did not have detectable levels of 
myomesin or M-protein.
BMC Physiology 2005, 5:12 http://www.biomedcentral.com/1472-6793/5/12
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was measured to ensure the functional integrity of the
muscles. Fatigue was induced with 500-ms submaximal
tetani (~50% of peak tetanic force) at 1.5 s intervals until
force declined by 50% or for 10 min, whichever occurred
first. Untreated control extraocular muscles sustained
forces above 50% of initial for the full duration of the
fatigue protocol. Control EDL bundles, on the other hand,
sustained forces above 50% of the initial for only 4.8 ± 0.5
min. DNFB accelerated the development of fatigue in EDL
bundles, such that 60 s into the fatigue protocol there was
already a significant difference between the control and
DNFB-treated muscles (figure 3A). At the end of the
fatigue protocol (270 s), control EDL muscles generated
44 ± 3% of the initial force vs. 32 ± 3% for DNFB-treated
EDL bundles (P < 0.05). By contrast, the extraocular mus-
cles proved more resistant to DNFB; the changes in force
during the fatigue protocol followed almost the same tra-
jectory with and without DNFB, and after 10 min peak
forces were not significantly different: control 60 ± 2 and
DNFB 57 ± 3% of initial force (figure 3B).
Upregulation of AK isoforms in extraocular muscle
The "myokinase" reaction (2 ADP → ATP + AMP), cata-
lyzed by AK, serves as an alternative ATP buffering system
in skeletal muscle. Total AK activity in extraocular muscles
was ~86% of the activity measured in EDL muscles, and
this difference was not statistically significant (figure 4A).
There are four known AK isoforms in rats, two of which
(AK1 and AK2) are found at relatively high levels in
skeletal muscle [16,17]. We used quantitative PCR to
determine the relative expression of the different AK iso-
forms in EDL and extraocular muscles. AK1 and AK2 were
detected at equivalent levels in the extraocular and EDL
muscles; differences were less than the 2-fold threshold
for significance (Figure 4B). However, mRNAs for AK3
and AK4 were over 13-fold more abundant in the extraoc-
ular muscles.
Discussion
The results from this study demonstrate that CK expres-
sion, content and activity are significantly lower in rat
extraocular muscles and that CK activity does not explain
Table 1: Contractile properties of EDL and extraocular muscles
TPT (ms) HRT (ms) PT/P0 (%) P0 (N/cm2) n
EDL 25.9 ± 0.5 25.4 ± 0.5 24.6 ± 1.7 24.2 ± 0.4 16
EOM 13.2 ± 0.4* 13.4 ± 0.4* 8.0 ± 0.6* 6.4 ± 0.2* 16
TPT, time to peak twitch force; HRT, half-relaxation time; PT/P0, twitch-to-tetanus ratio; P0, maximal tetanic force. EOM = extraocular muscles. * P 
< 0.001 EDL vs. extraocular muscle.
CK inhibition does not alter fatigue resistance of rat extraoc-ular muscleFigure 3
CK inhibition does not alter fatigue resistance of rat 
extraocular muscle. (A) DNFB (black triangles) decreases 
the fatigue resistance of EDL muscle bundles (n = 6 muscles 
per treatment, * P < 0.05 control vs. DNFB at the corre-
sponding time points). (B) DNFB (black circles) does not 
accelerate fatigue development in extraocular muscles (n = 6 
muscles per treatment). Vertical dotted line is included for 
comparison to mark to the end of the fatigue protocol for 
EDL muscles.
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the fatigue resistance of this muscle group, leading us to
reject our initial hypotheses.
Decreased CK expression and activity in extraocular 
muscle
CK is particularly abundant in fast-twitch skeletal mus-
cles; therefore, we measured total CK activity and CK iso-
form expression in EDL, a prototypical fast limb muscle,
and in the extraocular muscles, which are also composed
mostly of fast-twitch fibers. Surprisingly, CK activity was
significantly less in the extraocular muscles, only 20% of
the level measured in EDL. Message abundance and pro-
tein content of the muscle-specific CK-M were also lower
in the extraocular muscles (figure 1). A fraction of CK-M
is normally associated with the sarcomeric M lines, struc-
tures that support the thick filament lattice and are more
prominent in fast-twitch muscle fibers [4,6]. In conse-
quence, we explored whether low CK-M content corre-
lated with the absence of M lines characteristic of most rat
extraocular muscle fibers [12,13]. Our results confirmed
the previously described altered expression pattern of the
M line cytoskeletal components, myomesin and M-pro-
tein, in rodent extraocular muscles (figure 2) [13,18]. The
lack of M-protein is particularly intriguing since this
cytoskeletal protein is found almost exclusively in fast
twitch fibers [19,20]. This finding also correlates with the
description of fainter M lines in skeletal muscles from CK-
M knockout mice [21]; apparently the association of the
enzyme with the M lines contributes importantly to the
electron density of these structures. Myomesin was also
less abundant in extraocular muscle, as shown by immu-
nocytochemistry and western blot, despite the fact that
message levels were higher than in EDL. This finding is at
variance from our recent study of mouse extraocular mus-
cles [18]. It may indicate that post-transcriptional control
of myomesin expression is relatively more important in
the extraocular muscles of adult rats. Western blotting
confirmed that rat extraocular muscles contain an alterna-
tively spliced myomesin isoform, EH-myomesin, origi-
nally described in embryonic heart [22,23]. The fact that
this isoform was not detected by immunocytochemistry
in the present study may reflect low protein abundance.
Extraocular muscles express developmental and cardiac
markers [24]. Since the CK-MB heterodimer is the preva-
lent CK isoform in developing skeletal muscles and in
adult myocardium, we anticipated a relative upregulation
of CK-B in extraocular muscle compared to EDL. Our
results did not bear this out; CK-B mRNA and protein
were also significantly less in the extraocular muscles (fig-
ure 1).
Upregulation of AK isoforms in rat extraocular muscleFigure 4
Upregulation of AK isoforms in rat extraocular muscle. (A) Total AK activity in EDL and extraocular muscles (n = 9, P 
> 0.35). (B) Relative abundance of mRNAs for four AK isoforms in extraocular muscle by quantitative PCR. Each sample 
includes pooled muscles from 4 rats. Data are mean -fold differences (3–4 samples) in AK isoform expression and normalized 
to EDL muscle = 1.0, shown by the horizontal reference line. The abundance of AK1 and AK2 mRNAs was not significantly dif-
ferent in extraocular and EDL muscles (black bars). AK3 and AK4 are expressed at significantly higher levels in extraocular 
muscle (13.5- and 16.2-fold greater than EDL, respectively).
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Interestingly, the fast-twitch skeletal muscle fibers from
CK-M knockout mice have higher mitochondrial contents
and increased sCK activity [21]. Extraocular muscle fibers
have very high mitochondrial contents [12]. It has been
suggested that a greater number of mitochondria reduces
the diffusion distance between these organelles and
myofibrills and other ATP sinks, compensating for the
loss of cytosolic CK [21,25]. By analogy, the high mito-
chondrial content of extraocular muscles would achieve
the same goal, minimizing the need for the temporal and
spatial ATP buffering capacity normally provided by
cytosolic CK activity. Then, the movement of ATP from
mitochondria to cytosolic phosphocreatine may not be
required in the extraocular muscles. Despite the high
mitochondrial content of extraocular muscles, mRNA and
protein levels of sCK and uCK were lower in these mus-
cles; uCK was actually undetectable in the extraocular
muscles by quantitative PCR. The lower expression and
content of sCK are particularly puzzling; it has been pro-
posed that sCK mediates the high-energy phosphoryl flux
from mitochondria to cytosol and regulates oxidative
phosphorylation [26].
CK inhibition and fatigue resistance
The most physiologically significant finding in this study
was that CK inhibition with DNFB did not change the
fatigue resistance of the extraocular muscles, even though
it significantly accelerated the development of fatigue in
the fast-twitch muscle EDL (figure 3). The lack of effect of
DNFB on extraocular muscle fatigue was more impressive
because these muscles were stimulated at a higher fre-
quency than the EDL bundles in order to fulfill the
requirement that all muscles start the fatigue protocol at
50% of maximal force. In addition, endurance (time to
decrease force by 50%) was much longer in the extraocu-
lar muscles, since all EDL bundles reached this target force
by 3 min, and all extraocular muscles sustained forces
>50% of initial for 10 min. The use of phosphocreatine in
skeletal muscle energetics allows for high power output
and effective buffering of ATP concentration. While main-
tenance of constant ATP concentration during contractile
activity is neither universal not absolutely required, the
use of phosphocreatine as fuel increases the power output
attainable by skeletal muscles. This and delaying fatigue
after the onset of high-intensity stimulation are the most
perturbed functions in CK knockout mice [21,25]. How-
ever, CK activity may actually contribute to fatigue devel-
opment during prolonged stimulation by increasing the
cytosolic concentration of inorganic phosphate [27]. CK
would then be deleterious to a muscle group that is con-
stantly active and whose energy requirements may not
rely on traditional ATP buffers [28,29]. Because most skel-
etal muscle fibers are recruited during fairly short periods,
peak energy demand is much greater than the average
demand [30]. During these sporadic periods of peak
demand, CK provides the "metabolic capacitance" needed
to allow the system to have only enough mitochondria to
provide for average energy demand. Such arrangement
may not serve constantly active muscles such at the
extraocular muscles. Interestingly, skeletal muscles with
genetically impaired CK activity resemble the normal
extraocular muscle phenotype: high mitochondrial con-
tent, low force and power [12,31]. Both phenotypes
increase ATP generating capacity and decrease the size of
the ATP sinks.
Upregulation of AK isoforms in extraocular muscle
Preferential targeting of CK to myofibrillar and mitochon-
drial compartments serves to localize activity to where it is
needed, thus economizing enzyme distribution. This
would be particularly important in typical skeletal muscle
fibers where sparsely and non-uniformly distributed
mitochondria impose large diffusion distances [7]. But it
would be much less so in the mitochondria-rich and very
small extraocular muscle fibers, explaining the lack of M
lines and low CK activity. Instead, mRNAs for the mito-
chondria-associated AK3 and AK4 isoforms are present at
higher levels in these muscles, confirming an earlier gene
expression profile study that found AK4 at higher levels in
mouse extraocular muscles [28]. Interestingly, AK activity
is increased in CK-deficient mice, and inhibition of CK in
intact skeletal muscle results in increased phosphoryl
transfer via AK [32,33]. However, total AK activity was not
significantly different between EDL and extraocular mus-
cle. Whether the putative mitochondrial localization of
AK3 and AK4 is designed to replace CK activity associated
with mitochondria in the extraocular muscles remains to
be determined.
Another possible role for AK in extraocular muscle is that
it may mediate an alternative strategy for metabolic con-
trol. The lower expression of mitochondrial CK in extraoc-
ular muscles would diminish its proposed role for fine
regulation and amplification of the energy state signal
from the cytoplasm and control of mitochondrial oxida-
tive phosphorylation [26,34]. Instead, AMP from the AK-
catalyzed myokinase reaction would serve as a strong pos-
itive allosteric signal on 6-phosphofructo-1-kinase (PFK)
and inhibit fructose 1,6-bisphosphatase, activating glyco-
lysis. This control step could be particularly important in
the extraocular muscles given their apparent reliance on
fatty acid oxidation and glycolysis and not on glycogen
breakdown [28,29].
Conclusion
Our data indicate that the fatigue resistance of the fast and
constantly active extraocular muscles does not depend on
high CK activity. In consequence, the expression of the
known CK isoforms is downregulated in these muscles.
These findings strengthen emerging evidence that the
BMC Physiology 2005, 5:12 http://www.biomedcentral.com/1472-6793/5/12
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extraocular muscles follow a different strategy or design to
cope with their peculiar mechanical and metabolic loads.
Methods
Animals
Ethical use of experimental animals was approved by the
Institutional Animal Care and Use Committee. Three-
month old male Sprague Dawley rats (Harlan, Indianapo-
lis, IN) were anesthetized with ketamine hydrochloride/
xylazine hydrochloride (100 mg/8 mg per kg body weight,
i.p. injection) and killed by exsanguination following a
medial thoracotomy. For in vitro function, extraocular
muscles were dissected intact from bony origin to distal
tendon. Small EDL bundles were taken to yield a repre-
sentative fast limb skeletal muscle sample. For gene
expression and protein studies, all extraocular muscles
and mid-belly samples of EDL were quickly excised, fro-
zen in liquid nitrogen and stored at -80°C. For immuno-
cytochemistry, whole muscles were dissected, pinned to
cork at resting length, covered with OCT embedding
medium and frozen in 2-methylbutane cooled in liquid
nitrogen.
Enzyme assays
EDL and extraocular muscle samples were homogenized
(1:100 w/v) in 26 mM Tris, 30 mM dithiothreitol, 0.3 M
sucrose and 1% Triton X-100 (pH 8.0), and extracted on
ice for 1 hr. CK activity was determined in triplicate by a
hexokinase/glucose-6-phosphate dehydrogenase coupled
system, which yields NADH at a rate proportional to CK
activity (Sigma Chemical Co., St. Louis, MO), and
expressed as units/mg of protein. AK activity was deter-
mined in triplicate by a pyruvate kinase/lactate dehydro-
genase coupled system which follows the consumption of
NADH, and expressed as pmoles NADH/min/mg of pro-
tein. Protein content of muscle homogenates was deter-
mined by the Lowry method [35].
Real-time quantitative PCR
Muscles were pulverized under liquid nitrogen and total
RNA was isolated using Trizol (GibcoBRL, Rockville, MD)
according to the manufacturer's instructions. Muscles
from four animals were combined into each total RNA
sample to lessen the effect of inter-subject variability.
Reverse transcription was carried out using Superscript II
RNAse H- Reverse Transcriptase (Invitrogen, Carlsbad,
CA) with random hexamers. Primers for the mRNAs of
interest were designed with the software package Primer
Express version 1.5 (Applied Biosystems, Foster City, CA)
from GenBank nucleotide sequences and are shown in
Table 2. cDNA samples (2 µg each) were analyzed in trip-
licate with the ABI Prism 7700 Sequence Detection System
(Applied Biosystems) using ABI SYBR Green and β-actin
as the calibrator housekeeping gene. The relative abun-
dance of target mRNAs in the extraocular and EDL
muscles was determined with the comparative cycle
threshold method [36,37].
Immunocytochemistry
Five-µm thick longitudinal cryosections from extraocular
and EDL muscles were fixed with 2% paraformaldehyde,
blocked with 0.1% bovine serum albumin in phosphate-
buffered saline, and incubated overnight at 4°C with
monoclonal antibodies specific for myomesin or M-pro-
tein (BB78 and AA259, respectively) [38]. After washing
with phosphate-buffered saline, slides were incubated for
1 h in Alexa Fluor 488-conjugated secondary antibody
(1:50; Molecular Probes Inc., Eugene, OR), rinsed in
phosphate-buffered saline, and mounted in Immu-Mount
(Shandon, Pittsburgh, PA). Sections were examined and
imaged with a Zeiss LSM 410 confocal microscopy system.
Immunoblotting
For the analysis of myomesin, EH-myomesin, M-line pro-
tein and CK isoform content, tissue samples were homog-
enized in a buffer containing 26 mM Tris-HCl, 0.3 M
sucrose, 30 mM DTT and 1% Triton X-100; pH was
Table 2: Primer sequences for quantitative PCR
Name Size (bp) Forward / Reverse primers (5' → 3')
CK-M 76 GCCATGGTGGCTTCAAACC / CAGATCGTCTCCACCCTTGAG
CK-B 67 AAGCCCTGTCCAGCCTAGATG / CGCCTCGGTCATGCTCTT
sCK 73 GAGCTGGTGTCCACGTTAGGA / CCGCAGGTTCTCCAAGATCTT
uCK 82 CTGACCTTGATGCCAGCAAA / ACTTCGGCCAGTTCTGACTCTT
AK1 78 CTTCCAACGGCTTCTTGATTG / TGTGCGATCTTCCGTTCAAA
AK2 71 TGGAGGCCTACCACATCAGA / CAATGGCGCAGTGAATGA
AK3 75 ACCAGTTGTAGCTGGCTGTTG / TCTGATAAACTCTCCAGGGCTTCT
AK4 71 CTTCCAGCGGGAGGGTCTTAT / CGCCGGTGATGTCATCAAC
Myomesin 75 GGCCCACATTTCGCTGAGTA / TTGCCACCTTGCATTTCAAC
M-protein 96 GAGAGGGCGAGACAGTCACACT / CTCGTGGCTGTACTCTCCTCAGA
BMC Physiology 2005, 5:12 http://www.biomedcentral.com/1472-6793/5/12
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adjusted to 8.0. Western blots for myomesin, EH-myo-
mesin and M-protein were carried out using previously
described monoclonal antibodies and chemilumines-
cence [38]. Polyclonal antisera to synthetic peptides iden-
tical to rat amino acid sequences of the cytosolic CK-M
and CK-B (Rockland Immunochemicals), and sCK and
uCK (Affinity Bioreagents) were raised in New Zeland
white rabbits and collected by terminal bleeding. Specifi-
city of antisera was determined by ELISA and dot blot.
Western blots for CK isoforms were carried out as follows:
50 µg of total protein per sample were electrophoresed
and transferred to PVDF membranes. Blocked membranes
were probed with CK isoform-specific sera (1:1000), fol-
lowed by a horseradish peroxidase-conjugated secondary
antibody (Bio-Rad). Membranes were then developed
with 4-chloro-1 naphthol, scanned and analyzed using
ImageJ 1.30v [39].
Isolated muscle preparation
Whole extraocular muscles and small EDL muscle bun-
dles (~10–15% of total muscle mass) were placed in a
small muscle chamber. The distal tendon was attached to
a micropositioner and the proximal bone fragment to a
force transducer (AE801, SensoNor, Horten, Norway or
ELG-H, Entran, Fairfield, NJ). The chamber was super-
fused with a physiological salt solution: (in mM) 137
NaCl, 5 KCl, 2.0 CaCl2, 1.0 MgSO4, 1.0 Na2HPO4, 24
NaHCO3, 11 glucose, and 0.026 d-tubocurarine, bubbled
with a 95% O2-5% CO2 gas mixture to maintain pH at 7.4
at 25°C. To inhibit muscle CK activity, 2,4-dinitro-1-
fluorobenzene (DNFB, Sigma Chemical Co.) was added
to the bath from a 100 mM stock solution in dimethyl sul-
foxide (DMSO) [33,40,41]. Muscles were stimulated with
0.5 ms pulses delivered by an S48 stimulator (Grass
Instruments, Braintree, MA) to platinum electrodes in the
muscle chamber and stretched to the length giving maxi-
mum tetanic force (optimal length, L0). Force signals were
stored in a personal computer for analysis. At the end of
the study, the length of muscle fibers at L0 was measured
and bone and tendons removed. The muscles were blot-
ted dry and weighed. Force (in Newtons) was normalized
to muscle cross sectional area (cm2) [42].
Fatigue protocol
After measuring baseline contractile properties, muscles
were divided into two groups: DNFB-treated and time-
matched controls. Pilot studies demonstrated that 30-min
exposures to DMSO at the concentrations used here (0.01
to 0.05%) followed by 10-min washout had no effect on
the response to the fatigue protocol. Fatigue was induced
with the following protocol: muscles were stimulated at a
frequency giving approximately one half of maximal
tetanic force (30–50 Hz for EDL bundles, 50–70 Hz for
extraocular muscles) for 500 ms, followed by 1.5 s interval
between contractions, until force in the control group
declined to approximately 50% of the level at time = 0 or
for 10 min, whichever occurred first.
Data analysis
All results are presented as means ± s.e.m. of n observa-
tions, unless otherwise noted. Statistical significance was
determined at the 95% confidence level using Student's t
test for unpaired or paired samples as indicated; the treat-
ment effect in the fatigue runs was determined by analysis
of variance.
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